down arrow

Jacobson Pharma Corp. Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG677291067
HKD
1.27
-0.02 (-1.55%)

Feb 16

HKG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Jacobson Pharma Corp. Ltd.
JBM (Healthcare) Ltd.

Why is Jacobson Pharma Corp. Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of 1.91% and Operating profit at 10.39% over the last 5 years
2
Flat results in Mar 25
  • NO KEY NEGATIVE TRIGGERS
3
With ROE of 13.30%, it has a Fair valuation with a 1.20 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 2.42%, its profits have risen by 50.9% ; the PEG ratio of the company is 0.2
4
Underperformed the market in the last 1 year
  • The stock has generated a return of 2.42% in the last 1 year, much lower than market (Hang Seng Hong Kong) returns of 18.06%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Jacobson Pharma Corp. Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Jacobson Pharma Corp. Ltd. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Jacobson Pharma Corp. Ltd.
-100.0%
3.03
35.75%
Hang Seng Hong Kong
18.06%
0.71
25.51%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
1.91%
EBIT Growth (5y)
10.39%
EBIT to Interest (avg)
6.33
Debt to EBITDA (avg)
1.52
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.44
Tax Ratio
19.50%
Dividend Payout Ratio
59.41%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.92%
ROE (avg)
9.37%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
1.20
EV to EBIT
8.60
EV to EBITDA
6.18
EV to Capital Employed
1.18
EV to Sales
2.01
PEG Ratio
0.18
Dividend Yield
11.84%
ROCE (Latest)
13.75%
ROE (Latest)
13.30%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
ROCE(HY)

Highest at 12.47%

PRE-TAX PROFIT(Q)

Highest at HKD 215.14 MM

DIVIDEND PAYOUT RATIO(Y)

Highest at 68.07%

RAW MATERIAL COST(Y)

Fallen by -7.27% (YoY

DIVIDEND PER SHARE(HY)

Highest at HKD 7.32

OPERATING PROFIT MARGIN(Q)

Highest at 33.24 %

NET PROFIT(Q)

Highest at HKD 174.43 MM

EPS(Q)

Highest at HKD 0.08

0What is not working for the Company
NO KEY NEGATIVE TRIGGERS

Here's what is working for Jacobson Pharma Corp. Ltd.

Pre-Tax Profit
Highest at HKD 215.14 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (HKD MM)

Operating Profit Margin
Highest at 33.24 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
At HKD 215.14 MM has Grown at 50.11%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit
Highest at HKD 174.43 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (HKD MM)

EPS
Highest at HKD 0.08
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (HKD)

Dividend per share
Highest at HKD 7.32
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (HKD)

Dividend Payout Ratio
Highest at 68.07%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost
Fallen by -7.27% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jacobson Pharma Corp. Ltd.

Non Operating Income
Highest at HKD 0.27 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Download on App Store
Get it on Google Play
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."